טוען...
Caveolin-1 scaffolding domain peptide regulates glucose metabolism in lung fibrosis
Increased metabolism distinguishes myofibroblasts or fibrotic lung fibroblasts (fLfs) from the normal lung fibroblasts (nLfs). The mechanism of metabolic activation in fLfs has not been fully elucidated. Furthermore, the antifibrogenic effects of caveolin-1 scaffolding domain peptide CSP/CSP7 involv...
שמור ב:
| הוצא לאור ב: | JCI Insight |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Clinical Investigation
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7566714/ https://ncbi.nlm.nih.gov/pubmed/32841217 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.137969 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|